Morgan Stanley maintains Comcast (NASDAQ:CMCSA) with a Overweight and raises the price target from $70 to $72.
SVB Leerink Maintains Outperform on Intellia Therapeutics, Lowers Price Target to $152
SVB Leerink analyst Mani Foroohar maintains Intellia Therapeutics (NASDAQ:NTLA) with a Outperform and lowers the price target from $155 to $152.